BUZZ-HeartBeam rises on FDA clearance for heart-monitoring device

Reuters
16 Dec 2024
BUZZ-HeartBeam rises on FDA clearance for heart-monitoring device

** Shares of medical device maker HeartBeam BEAT.O rise 9.3% to $3.55 in premarket trading

** Company says the U.S. FDA cleared its device that can record the heart's electrical activity and help in detecting irregular heartbeats

** Says the credit card-sized device, when placed on the patient's chest, works by capturing the signals, which are then processed and sent to a physician for review

** Up to last close, stock up 32.8% YTD

(Reporting by Christy Santhosh)

((Christy.Santhosh@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10